Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taimur Sher

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|February 14, 2022
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive casesAmritpal Singh, Aref Al-Kali, Kebede H Begna, et al.
Leukemia & Lymphoma|June 1, 2013
Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cellsKasyapa S Chitta, A Nazmul H Khan, Noreen Ersing, et al.
British Journal of Haematology|February 19, 2015
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cellsKasyapa Chitta, Aneel Paulus, Sharoon Akhtar, et al.
Leukemia & Lymphoma|November 8, 2011
Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myelomaSikander Ailawadhi, Jeff Miecznikowski, Dan P Gaile, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
British Journal of Haematology|October 21, 2011
Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour responseAsher A Chanan-Khan, Kasyapa Chitta, Noreen Ersing, et al.
Psychosomatics|May 4, 2020
Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation RecipientsMadiha Iqbal, Aaron Spaulding, Shehzad Niazi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 15, 2021
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective studySikander Ailawadhi, Abhisek Swaika, Pooja Advani, et al.
Annals of Hematology|January 13, 2021
Utilization of radiation therapy in multiple myeloma: trends and changes in practiceSikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|February 14, 2022
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive casesAmritpal Singh, Aref Al-Kali, Kebede H Begna, et al.
Leukemia & Lymphoma|June 1, 2013
Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cellsKasyapa S Chitta, A Nazmul H Khan, Noreen Ersing, et al.
British Journal of Haematology|February 19, 2015
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cellsKasyapa Chitta, Aneel Paulus, Sharoon Akhtar, et al.
Leukemia & Lymphoma|November 8, 2011
Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myelomaSikander Ailawadhi, Jeff Miecznikowski, Dan P Gaile, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
British Journal of Haematology|October 21, 2011
Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour responseAsher A Chanan-Khan, Kasyapa Chitta, Noreen Ersing, et al.
Psychosomatics|May 4, 2020
Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation RecipientsMadiha Iqbal, Aaron Spaulding, Shehzad Niazi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 15, 2021
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective studySikander Ailawadhi, Abhisek Swaika, Pooja Advani, et al.
Annals of Hematology|January 13, 2021
Utilization of radiation therapy in multiple myeloma: trends and changes in practiceSikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, et al.
Pageof 12